ClinicalTrials.gg
Not yet recruitingNCT07718035Updated Jul 29, 2026

Evaluating the Effectiveness of the Moving to Emptiness Technique in Reducing Counsellors' Compassion Fatigue

An interventional study of Moving to Emptiness Technique (MET) in Compassion Fatigue, sponsored by University of Malaya. Not yet recruiting. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-29.

Sponsored by University of Malaya · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if Moving to Emptiness Technique (MET) works to treat counselors' compassion fatigue (CF). It will also learn about the effectiveness of MET on counselors' professional quality of life and counselling self-estimate. The main questions it aims to answer are:

  • Does MET reduce counselors' compassion fatigue? Researchers will compare MET intervention to a waitlist control group to see if MET works to treat counselor burnout.

Participants will:

  • Receive MET intervention for 4 sessions, once a week, 50 minutes per session.
  • Fill the questionnaires tests at three timepoints: before the intervention, immediately after the intervention phase and 4 weeks after the intervention.
Read the detailed description

Compassion fatigue (CF) is a type of caregiver burnout which is developed by those persons who interact with traumatized individuals. Psychological counsellors are at high risk of CF. Interventions for counsellors' CF from former research included mindfulness-based interventions, and group psychotherapy. Moving to emptiness technique (MET) is a native Chinese psychotherapy, targeting to eliminate negative physical and emotional symptoms. MET is effective for many mental illness and physical symptoms, including depression, agoraphobia, insomnia, back pain caused by ankylosing spondylitis. However, the effectiveness of MET in alleviating counsellors' CF has not been empirically studied. Thus, this study aims to explore the effectiveness and feasibility of the MET intervention on CF among psychological counsellors, and to explore the effectiveness of MET on additional outcomes including professional quality of life and counselling self-estimate.

Participants will be recruited using convenience sampling through online channels relevant to psychological counsellors, including social media, professional forums and WeChat groups. Participants will also be recruited through peer networks whereby researchers' colleagues will be invited to share the study information within their professional circles. Recruitment will be initiated by distributing an online study invitation containing a brief overview of the research and a link to the participant information sheet through Wenjuan Xing. Individuals who express interest will be directed to the main researcher from whom they will receive detailed study information, complete the initial eligibility screening, and provide informed consent electronically. Eligible participants will then be scheduled for an online interview to confirm inclusion and exclusion criteria. All recruitment, screening, and enrolment procedures will be conducted remotely to accommodate participants' availability and ensure accessibility for practitioners across locations.

This study is a four-week two-armed trial. One group will receive the MET therapy (intervention group) and the other group (waitlist control group) will have their usual care while being on a waitlist and will participate in MET therapy after the trial is over. After registration, participants need to fill out a personal information questionnaire and a pre-test questionnaire first. Then, they will be randomly assigned to the intervention group or control group. After 4 weeks, participants will need to take another post-test, and after another 4 week, they will fill out the tracking questionnaire. This study will take 2 months, with 4 weeks' intervention stage and 4 weeks' tracking effectiveness stage. Participants in the intervention group are required to participate in a 4-week online intervention using MET (once a week and 50 minutes for each session) and fill out personal information questionnaires and test questionnaires. The MET sessions will be conducted by trained MET professional counsellors. Participants in the waitlist control group also need to fill out personal information questionnaires and test questionnaires but will proceed with your usual care. After the trial is over, they will have an opportunity to receive the same 4-week online MET as the experimental group.

02

Conditions studied

  • Compassion Fatigue

Keywords

  • counselors
  • compassion fatigue
  • burnout
  • Moving to Emptiness Technique
  • Psychological Intervention
  • China
03

In context

Compassion Fatigue

60 studies on the registry are indexed under Compassion Fatigue; 21 are open to participants now.

This study's planned enrollment of 60 is close to the median of 64 across 45 interventional studies indexed under Compassion Fatigue.

Browse Compassion Fatigue studies →

Lead sponsor

University of Malaya is the lead sponsor of 284 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (aged 18-60)
  • Counsellors who have worked in the counselling profession for at least one year
  • Counsellors who self-report experiencing CF symptoms
  • Able to commit to attend the 4 weekly online sessions of 50 minutes' duration
  • Counsellors based in China

Exclusion criteria

Exclusion Criteria:

  • Counsellors have received psychological therapy for their CF within the last 6 months
  • Counsellors who intend to participate in other psychological therapy for their CF besides MET during the study duration
  • Counsellors who self-report experiencing a traumatic event within past one year
  • Counsellors who self-report severe mental illness within past one year
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    MET intervention

    Participants in the intervention group will receive MET intervention during the trial.

    Behavioral: Moving to Emptiness Technique (MET)

  • No intervention
    Waitlist control group

    Participants assigned to the waitlist control group receive no study intervention during the trial period. After completion of the final follow-up assessment, they will be offered the Moving to Emptiness Technique (MET).

Interventions

  • BehavioralMoving to Emptiness Technique (MET)

    The intervention is Moving to Emptiness Technique (MET), a native Chinese psychotherapy that integrates traditional Chinese cultural beliefs which focusses on the importance of the inner (psychological) world while including somatic (bodily) relaxation and the operational process of cognitive behavioural therapy. The delivery of MET intervention would be once a week, 50 minutes per session, across 4-weeks, to ensure the participants have enough rest between each session.

06

What researchers measure

Primary outcomes

  1. Compassion Fatigue

    Chinese validated Compassion Fatigue Questionnaire (Source: Wang Junting, 2024). The questionnaire contains 10 items rated on a 5-point Likert scale. Total scores range from 10 to 50, with higher scores indicating greater compassion fatigue.

    Time frame: Baseline, Week 4, Week 8

Secondary outcomes

  1. Professional Quality of Life scale

    Chinese validated Professional Quality of Life scale (Source: Zheng et al., 2013). The questionnaire consists of 30 items and assesses Compassion Satisfaction, Burnout, and Secondary Traumatic Stress. Each subscale score ranges from 10 to 50, with higher Compassion Satisfaction scores indicating greater compassion satisfaction, and higher Burnout and Secondary Traumatic Stress scores indicating worse burnout and secondary traumatic stress, respectively.

    Time frame: Baseline, Week 4, Week 8

  2. Counselling Self-Estimate

    Counselling Self-Estimate Inventory (Source: Yuen et al., 2004). The questionnaire contains 33 items rated on a 6-point Likert scale. Total scores range from 33 to 198, with higher scores indicating greater counselling self-efficacy.

    Time frame: Baseline, Week 4, Week 8

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — This study involves sensitive mental health data.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07718035
Responsible party
Sponsor
First posted
Jul 21, 2026
Start date
Jul 27, 2026 (estimated)
Primary completion
Jun 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Jul 29, 2026

Study contacts

Yu Gao, M.Ed.
Contact
gaoyu89757@gmail.com
+601163686780
Wen Ting Tong, PhD
Contact
tongwenting@um.edu.my
60166803231
Yew Kong Lee, PhD
principal investigator · Faculty of Medicine, Faculty of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion